Serum Levels of Soluble CD23, but not Soluble CD25, Predict Disease Progression in Early Stage B-Cell Chronic Lymphocytic Leukemia

Serum levels of the soluble forms of CD23 (sCD23) and CD25 (sCD25) were prospectively analyzed with respect to their prognostic relevance in early stage B-cell chronic lymphocytic leukemia (B-CLL). SCD23 and sCD25 levels were determined in 105 patients with newly diagnosed B-CLL (Binet stage A). In...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia & lymphoma 1997-11, Vol.27 (5-6), p.523-532
Hauptverfasser:	Knauf, W. U., Langenmayer, I., Ehlers, B., Mohr, B., Adorf, D., Nerl, C. H., Hallek, M., Zwingers, T. H., Emmerich, B., Thiel, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - blood Bone Marrow - physiology Chronic lymphocytic leukemia Disease Progression early stage Humans Leukemia, Lymphocytic, Chronic, B-Cell - blood Leukemia, Lymphocytic, Chronic, B-Cell - etiology Leukemia, Lymphocytic, Chronic, B-Cell - immunology Neoplasm Staging Receptors, IgE - blood Receptors, Interleukin-2 - blood Risk Factors soluble CD23 Statistics as Topic Thymidine Kinase - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!